Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/1999
10/28/1999WO1999054724A1 Process for evaluating chemical and biological assays
10/28/1999WO1999054718A1 Biochemical devices and their methods of manufacture
10/28/1999WO1999054707A2 Fetal testing for prediction of low birth weight
10/28/1999WO1999054510A2 Quantitative analysis of gene expression
10/28/1999WO1999054509A1 Methods for reducing non-specific binding to a nucleic acid probe array
10/28/1999WO1999054508A1 RAPID AND SENSITIVE METHOD FOR DETECTING $i(HISTOPLASMA CAPSULATUM)
10/28/1999WO1999054507A1 Repeat polymorphism in the frataxin gene and uses therefor
10/28/1999WO1999054506A1 Method of isolating target specific oligonucleotide ligands
10/28/1999WO1999054505A1 A protein that enhances expression of potassium channels on cell surfaces and nucleic acids that encode the same
10/28/1999WO1999054503A1 Simplified sequential chemiluminescent detection
10/28/1999WO1999054502A1 Method for the rapid determination of bacteria
10/28/1999WO1999054501A1 A method for the characterisation of nucleic acid molecules involving generation of extendible upstream dna fragments resulting from the cleavage of nucleic acid at an abasic site
10/28/1999WO1999054500A2 Biallelic markers for use in constructing a high density disequilibrium map of the human genome
10/28/1999WO1999054499A1 Method of analysis of chronic wounds
10/28/1999WO1999054498A1 Method for detecting allelic imbalance
10/28/1999WO1999054496A2 Method for typing of hla alleles
10/28/1999WO1999054495A1 Assay for screening inhibitors of c4 plant enzymes
10/28/1999WO1999054494A2 Multiparameter facs assays to detect alterations in cellular parameters
10/28/1999WO1999054493A2 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
10/28/1999WO1999054487A2 A method for isolating a polynucleotide of interest from the genome of a mycobacterium using a bac-based dna library. application to the detection of mycobacteria
10/28/1999WO1999054479A2 INHIBITION OF ALKYL HYDROPEROXIDE REDUCTASE, SUBUNIT C (AhpC) TO IMPART SUSCEPTIBILITY TO ANTIMICROBIAL REACTIVE NITROGEN INTERMEDIATES
10/28/1999WO1999054473A2 Bacterial yjeq polypeptide family
10/28/1999WO1999054469A1 B-cell growth factor related protein
10/28/1999WO1999054468A1 Soluble protein ztmpo-1
10/28/1999WO1999054467A1 Sh2 domain-containing peptides
10/28/1999WO1999054465A2 Gene encoding syntaxin interacting protein
10/28/1999WO1999054464A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
10/28/1999WO1999054463A2 Human k+ ion channel and therapeutic applications thereof
10/28/1999WO1999054461A2 Human nucleic acid sequences of endometrium tumour tissue
10/28/1999WO1999054460A2 Human nucleic acid sequences of normal bladder tissue
10/28/1999WO1999054456A1 ANTISENSE OLIGONUCLEOTIDES FOR THE INHIBITION OF INTEGRIN αv-SUBUNIT EXPRESSION
10/28/1999WO1999054455A1 Method for synthesizing dna
10/28/1999WO1999054447A2 Human nucleic acid sequences of bladder tumour tissue
10/28/1999WO1999054441A1 Efficient purification of adenovirus
10/28/1999WO1999054353A2 Human nucleic acid sequences of normal uterus tissue
10/28/1999WO1999054350A1 Novel omega conotoxin peptides
10/28/1999WO1999054348A1 Rapidly degrading gfp-fusion proteins and methods of use
10/28/1999WO1999054347A2 ALZHEIMER-ASSOCIATED β-AMYLOID BINDING PROTEIN (ERAB)
10/28/1999WO1999054343A2 Novel molecules of the t139-related protein family and uses thereof
10/28/1999WO1999054341A1 Enhanced antisense modulation of icam-1
10/28/1999WO1999054340A1 Endotoxin reduction in nucleic acid purification
10/28/1999WO1999053960A2 Enhancing immune responses to genetic immunization by using a chemokine
10/28/1999WO1999053927A1 Methods for treating and preventing insulin resistance and related disorders
10/28/1999WO1999053762A1 A method for efficient and highly selective control of microorganisms
10/28/1999WO1999045142A3 Agent and method for detecting chemical substances
10/28/1999WO1999042839A3 Treating cancer
10/28/1999WO1999042827A3 Device for detecting oligonucleotide and/or polynucleotide hybridization
10/28/1999WO1999042619A3 Association of the serotonin transport (htt) gene with cardiovascular disease and longevity
10/28/1999WO1999041379A9 Members of the d52 gene family
10/28/1999WO1999041378A9 Members of the d52 gene family
10/28/1999WO1999040946A3 Methods and compositions for modulating leptin activity
10/28/1999WO1999037763A9 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
10/28/1999WO1999037299B1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
10/28/1999WO1999036564A9 Multiplexed analysis of clinical specimens apparatus and methods
10/28/1999WO1999029898A3 Method for identifying nucleic acids by means of matrix-assisted laser desorption/ionisation mass spectrometry
10/28/1999WO1999027080A3 Human protein kinase and kinase inhibitors
10/28/1999WO1999025878A3 Methods for modulating and identifying cellular senescence
10/28/1999WO1999025724A3 Oligonucleotide synthesis using high boiling point solvents
10/28/1999WO1998050576A8 Betaines as adjuvants to susceptibility testing and antimicrobial therapy
10/28/1999WO1998040099A9 Leptospira pathogens
10/28/1999DE19918479A1 Isolated nucleic acid for the GC-3 fragment from Neisseria gonorrhoeae, useful for species-specific detection
10/28/1999DE19903693A1 Protease zur Aktivierung des Gerinnungsfaktors VII Protease for activation of coagulation factor VII
10/28/1999DE19818620A1 New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents
10/28/1999DE19818619A1 New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents
10/28/1999DE19818422A1 Method for determining absolute mutagenicity and error rate of polymerases in amplification reactions
10/28/1999DE19818184A1 Determining the presence of microorganisms in compressed air, useful for pharmaceutical industry
10/28/1999DE19818077A1 Fixing substrate molecules in gel matrixes
10/28/1999CA2658218A1 Improved immunodiagnostic assays using reducing agents
10/28/1999CA2328967A1 A method for efficient and highly selective control of microorganisms
10/28/1999CA2328888A1 Rapidly degrading gfp-fusion proteins and methods of use
10/28/1999CA2327800A1 Process for evaluating chemical and biological assays
10/28/1999CA2326725A1 Method for synthesizing dna
10/28/1999CA2326691A1 Method for the rapid determination of bacteria
10/28/1999CA2326685A1 Enhancing immune responses to genetic immunization by using a chemokine
10/28/1999CA2326670A1 Ikb and enhanced green fluorescent fusion protein
10/28/1999CA2326623A1 Gene encoding syntaxin interacting protein
10/28/1999CA2326621A1 Immobilized substrate, separation gels and method for detecting enzymatic activity
10/28/1999CA2326498A1 Methods for reducing non-specific binding to a nucleic acid probe array
10/28/1999CA2325864A1 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy
10/28/1999CA2325848A1 B-cell growth factor related protein
10/28/1999CA2325822A1 Soluble protein ztmpo-1
10/28/1999CA2325821A1 Antisense oligonucleotides for the inhibition of integrin .alpha.v-subunit expression
10/28/1999CA2325663A1 Novel mutations in the freac3 gene for diagnosis and prognosis of glaucoma and anterior segment dysgenesis
10/28/1999CA2325343A1 Quantitative analysis of gene expression
10/28/1999CA2324975A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/28/1999CA2324866A1 Biallelic markers for use in constructing a high density disequilibrium map of the human genome
10/28/1999CA2324297A1 Sh2 domain-containing peptides
10/28/1999CA2323571A1 Novel human k+ ion channel and therapeutic applications thereof
10/27/1999EP0952228A2 Compositions and methods for enhancing hybridization specificity
10/27/1999EP0952220A2 Method to predict active growth of bacteria adhered to a surface
10/27/1999EP0952216A2 Solid phase supports with PNA and amidate tag compliments
10/27/1999EP0952215A2 Protease for activating clotting factor VII
10/27/1999EP0952211A1 Method for detecting micro-organisms and cartridge suitable for implementing it
10/27/1999EP0952210A1 Cartridge as well as air analysis method and apparatus using it
10/27/1999EP0952209A2 Device and method for differentiation and identification of enterobacteria
10/27/1999EP0951569A2 Customized oligonucleotide microchips as multiple biosensors
10/27/1999EP0951568A1 Methods for detecting and inhibiting the rna component of telomerase
10/27/1999EP0951567A1 Use of prostate tumor inducing gene for detection of cancer cells
10/27/1999EP0951566A1 A method of purifying dna
10/27/1999EP0951565A1 Improved probing of specific nucleic acids
1 ... 2600 2601 2602 2603 2604 2605 2606 2607 2608 2609 2610 2611 2612 2613 2614 2615 2616 2617 2618 2619 2620 ... 3003